Cushing's Syndrome Diagnostic & Treatment Market (2018-2023) Featuring Novartis, Corcept Therapeutics, StrongBridge Biopharma, Orphagen Pharma, and HRA Pharma - ResearchAndMarkets.com
Sep. 11, 2018
DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Cushing's Syndrome Diagnostic and Treatment Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The Global Cushing's Syndrome Diagnostic & Treatment Market is expected to grow at a CAGR of 8.28% to reach a total market size of US$404.546 million by 2023, increasing from US$250.992 million in 2017.
Cushing's disease is a condition characterized by the presence of excess steroid hormone cortisol' or stress hormone in blood vessels and is caused by improper functioning of pituitary glands which are responsible for secreting adrenocorticotropic hormone (ACTH).
ACTH stimulates the adrenal glands (located on top of the kidneys) to produce cortisol. Typical symptoms of the Cushing's syndrome are weight gain, an appearance of pink or purple stretch marks and thinning and easily bruised skin and occasionally type 2 diabetes. Treatment includes reducing the use of corticosteroids, surgery, and medications.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Disease Overview
5. Cushing's Syndrome Diagnostic & Treatment Industry Overview
6. Cushing's Syndrome Diagnostic & Treatment Market Forecast by Diagnostic techniques
7. Cushing's Syndrome Diagnostic & Treatment Market Forecast by Treatment
8. Cushing's Syndrome Diagnostic & Treatment Market Forecast by Geography
9. Competitive Intelligence
10. Company ProfilesNovartis Corcept Therapeutics Inc. StrongBridge Biopharma Orphagen Pharmaceuticals Inc. HRA Pharma
For more information about this report visit https://www.researchandmarkets.com/research/mfx7b7/cushings?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005701/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/11/2018 01:51 PM/DISC: 09/11/2018 01:51 PM